Literature DB >> 26542613

Pattern Recognition in Pharmacodynamic Data Analysis.

Johan Gabrielsson1, Stephan Hjorth2,3.   

Abstract

Pattern recognition is a key element in pharmacodynamic analyses as a first step to identify drug action and selection of a pharmacodynamic model. The essence of this process is going from data to insight through exploratory data analysis. There are few formal strategies that scientists typically use when the experiment has been done and data collected. This report attempts to ameliorate this deficit by identifying the properties of a pharmacodynamic model via dissection of the pattern revealed in response-time data. Pattern recognition in pharmacodynamic analyses contrasts with pharmacokinetic analyses with respect to time course. Thus, the time course of drug in plasma usually differs markedly from the time course of the biomarker response, as a consequence of a myriad of interactions (transport to biophase, binding to target, activation of target and downstream mediators, physiological response, cascade and amplification of biosignals, homeostatic feedback) between the events of exposure to test compound and the occurrence of the biomarker response. Homing in on this important-but less often addressed-element, 20 datasets of varying complexity were analyzed, and from this, we summarize a set of points to consider, specifically addressing baseline behavior, number of phases in the response-time course, time delays between concentration- and response-time courses, peak shifts in response with increasing doses, saturation, and other potential nonlinearities. These strategies will hopefully give a better understanding of the complete pharmacodynamic response-time profile.

Keywords:  duration of response; exploratory data analysis; intensity of response; mixture dynamics; modeling; onset of action; oscillatory response; physiological limit; response half-life; response-time courses; saturation; transduction; turnover

Mesh:

Substances:

Year:  2015        PMID: 26542613     DOI: 10.1208/s12248-015-9842-5

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  28 in total

Review 1.  Serotonin autoreceptor function and antidepressant drug action.

Authors:  S Hjorth; H J Bengtsson; A Kullberg; D Carlzon; H Peilot; S B Auerbach
Journal:  J Psychopharmacol       Date:  2000-06       Impact factor: 4.153

2.  A nonlinear feedback model capturing different patterns of tolerance and rebound.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  Eur J Pharm Sci       Date:  2007-06-13       Impact factor: 4.384

3.  Mixture dynamics: dual action of inhibition and stimulation.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  Eur J Pharm Sci       Date:  2013-07-04       Impact factor: 4.384

4.  Dose-response-time data analysis involving nonlinear dynamics, feedback and delay.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  Eur J Pharm Sci       Date:  2014-04-19       Impact factor: 4.384

5.  Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

Authors:  V F Smolen
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534

6.  Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice.

Authors:  Nelson L Jumbe; Yan Xin; Douglas D Leipold; Lisa Crocker; Debra Dugger; Elaine Mai; Mark X Sliwkowski; Paul J Fielder; Jay Tibbitts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-04-28       Impact factor: 2.745

7.  Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples.

Authors:  Johan Gabrielsson; Stephan Hjorth; Barbara Vogg; Stephanie Harlfinger; Pablo Morentin Gutierrez; Lambertus Peletier; Rikard Pehrson; Pia Davidsson
Journal:  Eur J Pharm Sci       Date:  2014-11-28       Impact factor: 4.384

8.  Differences in the in vitro and in vivo 5-hydroxytryptamine extraction performance among three common microdialysis membranes.

Authors:  R Tao; S Hjorth
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

9.  Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study.

Authors:  S Hjorth
Journal:  J Neurochem       Date:  1993-02       Impact factor: 5.372

10.  Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

View more
  4 in total

1.  Landmark and longitudinal exposure-response analyses in drug development.

Authors:  Chuanpu Hu; Honghui Zhou; Amarnath Sharma
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-07-20       Impact factor: 2.745

2.  Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease.

Authors:  Chuanpu Hu; Omoniyi J Adedokun; Yang Chen; Philippe O Szapary; Christopher Gasink; Amarnath Sharma; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-06-16       Impact factor: 2.745

3.  Frequency-Domain Response Analysis for Quantitative Systems Pharmacology Models.

Authors:  Pascal Schulthess; Teun M Post; James Yates; Piet H van der Graaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-11-28

Review 4.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.